AI assistant
ABBOTT LABORATORIES — Director's Dealing 2008
Feb 13, 2008
29777_dirs_2008-02-12_37ffb7bd-e821-4f29-8e66-eebc987ad79e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-08
Reporting Person: Landgraf John C (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-08 | Common shares without par value | M | 1879 | $53.19 | Acquired | 106086 | Direct |
| 2008-02-08 | Common shares without par value | S | 800 | $56.91 | Disposed | 105286 | Direct |
| 2008-02-08 | Common shares without par value | S | 1079 | $56.74 | Disposed | 104207 | Direct |
| 2008-02-08 | Common shares without par value | S | 13500 | $56.90 | Disposed | 90707 | Direct |
| 2008-02-08 | Common shares without par value | S | 3300 | $56.89 | Disposed | 87407 | Direct |
| 2008-02-08 | Common shares without par value | S | 3200 | $56.88 | Disposed | 84207 | Direct |
| 2008-02-11 | Common shares without par value | M | 8421 | $56.30 | Acquired | 92628 | Direct |
| 2008-02-11 | Common shares without par value | S | 8421 | $56.33 | Disposed | 84207 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-08 | Option (right to buy) | $53.19 | M | 1879 | Disposed | 2008-02-12 | common shares (1879) | Direct |
| 2008-02-11 | Option (right to buy) | $56.30 | M | 8421 | Disposed | 2008-02-12 | common shares (8421) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 15494 | Indirect |
| Common shares without par value | 25000 | Indirect |
| Common shares without par value | 1296 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 8, 2008.
F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
F4: Reporting person disclaims beneficial ownership of all securities held by his son.
F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.